3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
9
Neoplasms
3
Brain Neoplasms
3
Medulloblastoma
2
Glioma
2
Sarcoma
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Kidney Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
Nivolumab
3
sodium-iodide symporter
2
fludarabine
2
cemiplimab
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Photons
2
Mycophenolic Acid
2
Immunoglobulin G
2
Disulfides
2
Cyclosporine
2
10-propargyl-10-deazaaminopterin
2
treosulfan
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
entrectinib
1
duvelisib
1
ceritinib
1
belinostat
1
alectinib
1
Vincristine
1
Vinblastine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
Lomustine
×
90 days
×
Clear all
No trials found.